FDA, mifepristone and abortion
Digest more
Top News
Impacts
Reactions and opinions
As the Food and Drug Administration undertakes a full agency review of the safety of the chemical abortion drug mifepristone, four pro-abortion attorneys general are asking the FDA to reverse course and lift all remaining restrictions on the drug.
Four attorneys general filed a petition with the FDA to lift restrictions on the abortion medication mifepristone.
A new peer-reviewed study by the pro-life Charlotte Lozier Institute (CLI) found no evidence to substantiate the popular claim that abortion
The new law adds another layer of protection for abortion providers in Maine who have raised concerns about safety and legal punishment.
Explore more